Back to Trades
VERTEX PHARMACEUTICALS INC / MA
VRTXCIK: 0000875320
VERTEX PHARMACEUTICALS INC / MA (VRTX) has recorded 50 insider filings from 20 unique insiders, totaling $103.6M in trading activity (net selling). Insiders have sold $40.6M while purchasing $0. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is Sachdev Amit. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$103.6M
Purchases
$0
Sales
$40.6M
Unique Insiders
20
Recent Insider Trades (50)
Grant
$0
1 grant
Other
$0
Grant
$0
1 grant
Other
$0
Other
$0
Sell
$469.2K
1 sale
Sell
$134.7K
1 sale1 grant
Grant
$0
1 grant
Grant
$0
1 grant
Other
$0
Other
$0
Sell
$439.3K
1 sale
Sell
$1.1M
1 sale
Sell
$442.4K
1 sale
Sell
$1.1M
1 sale
Ambrose KristenSVP & Chief Accounting Officer
Filed Mar 2, 2026
Sell
$172.6K
1 sale
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
Filed Feb 26, 2026
Sell
$126.5K
1 sale
Other
$0
Other
$0
Kewalramani ReshmaCEO & President, Director
Filed Feb 26, 2026
Other
$0
Ambrose KristenSVP & Chief Accounting Officer
Filed Feb 26, 2026
Sell
$108.5K
1 sale
Sell
$459.6K
1 sale
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
Filed Feb 26, 2026
Sell
$324.9K
1 sale
McKechnie DuncanEVP, Chief Commercial Officer
Filed Feb 26, 2026
Sell
$2.4M
2 sales
Sachdev AmitEVP Chief Patient & Ext Af Off
Filed Feb 26, 2026
Sell
$897.8K
1 sale
Other
$0
Sell
$301.5K
1 sale
Sachdev AmitEVP Chief Patient & Ext Af Off
Filed Feb 23, 2026
Sell
$27.5M
8 sales
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
Filed Feb 19, 2026
Sell
$472.4K
2 sales1 grant
Grant
$0
1 grant
McKechnie DuncanEVP, Chief Commercial Officer
Filed Feb 19, 2026
Grant
$0
1 grant
Kewalramani ReshmaCEO & President, Director
Filed Feb 19, 2026
Grant
$0
1 grant
Kewalramani ReshmaCEO & President, Director
Filed Feb 18, 2026
Other
$0
Other
$0
Other
$0
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
Filed Feb 18, 2026
Sell
$750.0K
1 sale
Sachdev AmitEVP Chief Patient & Ext Af Off
Filed Feb 18, 2026
Other
$0
Ambrose KristenSVP & Chief Accounting Officer
Filed Feb 18, 2026
Other
$0
Other
$0
Other
$0
Sell
$886.3K
1 sale
Kewalramani ReshmaCEO & President, Director
Filed Feb 12, 2026
Other
$0
Sell
$930.5K
1 sale
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
Filed Feb 12, 2026
Sell
$214.6K
1 sale
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
Filed Feb 12, 2026
Sell
$806.2K
1 sale
McKechnie DuncanEVP, Chief Commercial Officer
Filed Feb 12, 2026
Other
$0
Ambrose KristenSVP & Chief Accounting Officer
Filed Feb 12, 2026
Sell
$633.6K
1 sale
Sachdev AmitEVP Chief Patient & Ext Af Off
Filed Feb 12, 2026
Other
$0
Other
$0
Grant
$0
2 grants